We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Q&A Guidance Clarifies Criteria for EMA Adaptive Licensing Pilot
Q&A Guidance Clarifies Criteria for EMA Adaptive Licensing Pilot
A question-and-answer document released by the European Medicines Agency in September clarifies terms of engagement and expected outcomes for applicants to the agency’s adaptive licensing pilot program.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor